Clinical Updates | Conference Update Resource List

Last Updated on May 17, 2020 by HepFree NYC
Tags: HepCX NewsA network building capacity to prevent, manage and treat hepatitis B and C in NYC

Last Updated on May 17, 2020 by HepFree NYC
Tags: HepCX NewsA successful Viral Hepatitis Research Symposium took place on May 24, 2018 at Rockefeller University. This event brought together more than 200 local medical providers, laboratory directors, community service providers, policy-makers and other stakeholders, and DOHMH staff to r...
New York State has expanded COVID-19 vaccine eligibility to people with certain medical conditions, which includes liver disease (such as hepatitis B, hepatitis C, cirrhosis or other liver disease).
Please join Hep B United and the National Viral Hepatitis Roundtable on Monday, April 10, 2017 at 2:00 pm EDT
Hep C Peer Navigator Apply Now Position Overview/Summary Description: The Hep C Peer Navigator’s (PN) role is to assist individuals who have known Hep C infection and those at high risk with navigation and care coordination services. Other activities include conducting outreach...
Elected officials, community leaders and public health officials will announce free and low cost hepatitis screenings and unveil a new PSA campaign in New York City, San Francisco and Los Angeles.
The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
Advisory Board NYC Hep C Task Force Emily Winkelstein, MSW, Cross Systems Program Specialist, NYC Health Department, Bureau of Alcohol & Drug Use Prevention, Care & Treatment. (ewinkelstein@health.nyc.gov) is currently working in the NYC Health Department Alcohol and Drug...